Related Experiment Video
Updated: Jan 12, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
Decoding noncoding RNAs in regulating cardiovascular aging and age-related conditions: the emerging landscape
Zhiguo Wang1,2,3,4, Xiaofang Zhang5,6, Wenyue Li5,6
1Academician Collaborative Laboratory for Basic Research and Translation of Chronic Diseases, Central Laboratories, the First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, 511436, China. wzgmails@foxmail.com.
Non-coding RNAs (ncRNAs) are crucial in cardiovascular aging (CVA) and related diseases (AR-CVDs). Understanding their roles offers new strategies against age-related heart conditions.
Area of Science:
- Biomedical Sciences
- Molecular Biology
- Cardiology
Background:
- Cardiovascular disease (CVD) is a leading global cause of death.
- Cardiovascular aging (CVA) contributes to systemic aging and exacerbates CVDs.
- Non-coding RNAs (ncRNAs) are implicated in CVA and associated CVDs (AR-CVDs).
Purpose of the Study:
- To review the current understanding of ncRNAs in CVA and AR-CVDs.
- To explore the diverse roles of miRNAs, lncRNAs, and circRNAs in cardiovascular aging.
- To provide a holistic perspective on ncRNA regulation in aging and cardiovascular health.
Main Methods:
- Review of published studies on ncRNAs in aging and cardiovascular disease models.
- Analysis of in vitro and in vivo data on ncRNA functions.
- Integration of findings on miRNAs, lncRNAs, and circRNAs in CVA and AR-CVDs.
Main Results:
- ncRNAs act as pro-aging, anti-aging, or dual regulators in CVA.
- ncRNAs modulate vascular and cardiac aging through specific substrates and triggers.
- ncRNAs contribute to senescence and phenotypes like hypertension, atherosclerosis, and heart failure.
Conclusions:
- ncRNAs play significant regulatory roles in CVA and AR-CVDs.
- Understanding ncRNA networks offers insights into aging cardiovascular pathophysiology.
- Further research into ncRNAs may lead to novel therapeutic strategies for AR-CVDs.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Regulation of Heart Rates
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
Types of RNA
RNA Performs Diverse...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
